In The News Posted May 26, 2020 Share Posted May 26, 2020 KRAKOW, Poland, May 26, 2020 /PRNewswire/ -- The shareholders of Selvita S.A. [WSE:SLV] - one of the largest preclinical contract research organizations in Europe, have made a decision to go ahead with the issue of no more than 2.38 million C series shares, which constitutes about 15...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.